Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| LYELL IMMUNOPHARMA INC | 0 | 7,102,190 | +7,102,190 | 0 | 4,545 | 2.66% | +4,545 |
| PHARVARIS N V COM | 4,289,304 | 4,289,304 | 0 | 79,438 | 82,226 | 48.17% | +2,788 |
| ALX ONCOLOGY HLDGS INC | 9,699,925 | 9,699,925 | 0 | 17,654 | 16,199 | 9.49% | -1,455 |
| HARMONY BIOSCIENCES HLDGS IN(HRMY) | 614,594 | 539,194 | -75,400 | 24,584 | 18,554 | 10.87% | -6,030 |
| ACELYRIN INC | 3,852,470 | 3,806,410 | -46,060 | 18,993 | 11,952 | 7.00% | -7,041 |
| ARTIVA BIOTHERAPEUTICS INC | 1,519,971 | 1,519,971 | 0 | 23,484 | 15,321 | 8.98% | -8,162 |
| ALUMIS INC | 2,826,048 | 2,787,398 | -38,650 | 30,182 | 21,909 | 12.83% | -8,273 |